SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-015688
Filing Date
2019-08-07
Accepted
2019-08-07 06:53:10
Documents
94
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20190630_10q.htm 10-Q 1481225
2 EXHIBIT 31.1 ex_152437.htm EX-31.1 8978
3 EXHIBIT 31.2 ex_152438.htm EX-31.2 9208
4 EXHIBIT 32.1 ex_152439.htm EX-32.1 4448
5 EXHIBIT 32.2 ex_152440.htm EX-32.2 4459
  Complete submission text file 0001437749-19-015688.txt   9176421

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nby-20190630.xml EX-101.INS 2009831
7 XBRL TAXONOMY EXTENSION SCHEMA nby-20190630.xsd EX-101.SCH 104401
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nby-20190630_cal.xml EX-101.CAL 58482
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20190630_def.xml EX-101.DEF 667303
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20190630_lab.xml EX-101.LAB 552424
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20190630_pre.xml EX-101.PRE 704260
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 191003772
SIC: 2834 Pharmaceutical Preparations